Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation

BACKGROUND AND PURPOSE: Few data are available concerning the safety of bevacizumab (B) in combination with locoregional radiation therapy (RT). The objective of this study was to evaluate the 5-year late toxicity of concurrent B and RT in non-metastatic breast cancer. MATERIALS AND METHODS: This mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Clément-Zhao, Alice, Tanguy, Marie-Laure, Cottu, Paul, De La Lande, Brigitte, Bontemps, Patrick, Lemanski, Claire, Baumann, Pierre, Savignoni, Alexia, Levy, Christelle, Peignaux, Karine, Reynaud-Bougnoux, Agnès, Gobillion, Aline, Kirova, Youlia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716668/
https://www.ncbi.nlm.nih.gov/pubmed/31469859
http://dx.doi.org/10.1371/journal.pone.0221816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716668/
https://www.ncbi.nlm.nih.gov/pubmed/31469859
http://dx.doi.org/10.1371/journal.pone.0221816

Ejemplares similares